tert-Butyl (S)-(4-(2,5-dioxooxazolidin-4-yl)butyl)carbamate, 97%, 250mg

7-Fluoro-5-methoxy-2,3-dihydro-1H-inden-1-one, 97%, 1g

4-Methyloxane-4-carboxylic acid, 95.0%, 250mg

3-Amino-5-(trifluoromethyl)benzoic Acid>97.0%(HPLC)(T)1g

Obiettivo EPLPH 20x/0,40 fase E-Plan. Distanza di lavoro 1,85 mm

2-(4-Bromophenyl)-4,6-diphenyl-1,3,5-triazine, 95.0%, 10g

1-[4-(3-methylphenoxy)phenyl]methanamine, 100mg

6-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tosyl-1H-pyrrolo[2,3-c]pyridin-7(6H)-one, 97%, 50mg

Methyl 6-bromo-3-hydroxypicolinate, 95.0%, 250mg

(3-((4-Methoxybenzyl)oxy)phenyl)boronic acid, 98%, 1g

(S)-N-((3-(3-Fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methyl)acetamide, 95.0%, 25g

4-Bromomethylbenzoic acid tert-butyl ester, 98.0%, 5g

1,2-Pentanediol>98.0%(GC)500mL